Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 21, 2025Journal of Cardiovascular ImagingOpen Access

Genetic insights into hypertrophic cardiomyopathy: pathogenesis, diagnosis, and therapeutic implications

View Full Paper
Ask AI
Bookmark
Share

Authors

ECEui‐Young ChoiHCHyemoon ChungKLKyung‐A Lee

Discussion

Loading...

Member takes

Overview

Literature review highlights genetic testing outcomes and adverse cardiovascular events in hypertrophic cardiomyopathy, suggesting improved risk management.

Key Points

  • Sarcomeric mutations account for about 60% of familial hypertrophic cardiomyopathy cases, with variable effects on symptoms.
  • Patients with sarcomere-positive HCM are diagnosed 13 years earlier and face nearly double the incidence of cardiovascular events.
  • Genetic testing identifies atypical cases and supports family cascade testing and reproductive choices.
  • Emerging therapies like myosin inhibitors and gene editing hold promise for targeting the mechanisms of hypertrophic cardiomyopathy.

Cite This Study

Choi et al. (2025) studied this question.

synapsesocial.com/papers/689a060ee6551bb0af8cd1c1https://doi.org/10.1186/s44348-025-00055-4
View Full Paper
Ask AI
Bookmark
Share